×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Britain's drugmaker GSK buys US vaccine firm Affinivax in $3.3-billion deal

The London-listed company has agreed to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones for Affinivax
Last Updated : 31 May 2022, 10:26 IST

Follow Us :

Comments
ADVERTISEMENT
Published 31 May 2022, 09:34 IST

Follow us on :

Follow Us